Biobanks ensuring the governance and management of biological resources have become essential entities. The development of biotechnologies, the increased prevalence of biological drugs and the identification of biomarkers associated with molecular classifications of tissue lesions make it essential to have organized access to human biological samples, which have become precious and rare. The digital era and the production of massive data that comes with it have rendered biobanks the guarantors of the reproducibility of experiments and of the overall quality of medical research.
Biobanks in Healthcare explores the upheaval linked to the massive deployment of digital health and precision medicine. The future of health biology lies in the deployment of biobanks in fields that have yet to be explored, putting them at the forefront of this extraordinary 21st-century research adventure.
1. Biobanks, a Source of Human Samples and Health Data.
2. Biobanks in the Digital Age and Precision Medicine.
3. The Biobanking Lexicon.
Nicole Arrighi is an associate professor at Côte d’Azur University and teacher–researcher in the Biology and Pathologies of Melanocytes team (C3M, Nice), France. She is also the deputy director of the Biobanks and Complex Data Management master’s program.
Paul Hofman is a professor and hospital practitioner in pathology at Côte d’Azur University, France. He is the director of the Laboratory of Clinical and Experimental Pathology and the biobank at the Nice University Hospital. He leads a research team at the Institute for Research on Cancer and Aging and the OncoAge University Hospital Federation.
Table of Contents
PDF File 171 Kb